[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [@BiopharmIQ](/creator/twitter/BiopharmIQ) "Biotech Stock Catalyst Watchlist ๐ฏ Ph2 & Ph3 readouts in Q3 2025. $TRML Phase X $CGEM Phase X $PMVP Phase X $IMVT Phase X $ATYR Phase X $ARCT Phase X $IONS Phase X $MLTX Phase X $QURE Phase 2/3 $ENTA Phase X $KALA Phase 2b $LTRN Phase X $LRMR Phase X $ENTX Phase X $KAPA Phase X $RAPP Phase 2a $MTSR Phase 2b $PRAX Phase X $ATAI Phase 2b $GRI Phase 2a $HRMY Phase X $CLNN Phase X $FBIO Phase X $UPB Phase X $LGVN Phase 2a $SKYE Phase 2a Check out the image for more details" [X Link](https://x.com/BiopharmIQ/status/1962194015820116329) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-08-31T16:41Z 27.4K followers, 48K engagements "๐ข M&A News: Genmab $GMAB to acquire Merus $MRUS for $8B ๐ฐ $97/share all-cash (41% premium $8B EV) ๐งฌ Adds Phase X bispecific petosemtamab (BTD in head & neck cancer) Ph2 data showed strong ORR & PFS SOC; Ph3 readouts in 2026 Expected launch 2027 $1B sales by 2029 multi-billion potential longer term ๐ Closing by Q1 2026 See photo for more info ๐" [X Link](https://x.com/BiopharmIQ/status/1972672796154355942) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-09-29T14:40Z 27.4K followers, 10.4K engagements "Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q4 2025 (1/3). $PTGX Phase 2b $EVAX Phase X $DCTH Phase X $CELC Phase X $IDYA Phase X $IDYA Phase 2/3 $KYTX Phase X $VOR Phase X $INBX Phase X $ATAI Phase 2b $LQDA Phase X $PROK Phase X $KZR Phase 2a $ALXO Phase X $ELDN Phase X $IFRX Phase 2a $IFRX Phase 2b $NKTR Phase 2b $RZLT Phase X $PVLA Phase X $BDTX Phase X $RNA Phase X $CAPR Phase X $TARA Phase X $ZVSA Phase 2a $CGON Phase X $VTYX Phase X $DBVT Phase X $PHVS Phase X $VTGN Phase X $TERN Phase X $ALEC Phase X $ZBIO Phase X $IRON Phase X $INBX Phase 2/3 $MLTX Phase X $ANAB Phase 2" [X Link](https://x.com/BiopharmIQ/status/1974933700845715618) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-10-05T20:24Z 27.4K followers, 55.3K engagements "๐ Biotech Stock News 10/10 @ Open $CDTX X% Present @ 10th ESWI Influenza Conf. $AZN X% Expand VA Manuf. Facility $OSTX X% OST-HER2 Ph2b OS Data $JNJ X% MDD Portfolio @ 2025 ECNP Congress $CRSP X% New Preclinical CTX460 Data $BIIB -X% New Zorevunersen Data @ 54th CNS Mtg. $BMY -X% To Acquire Orbital Therapeutics $ASMB -X% ABI-5366 Interim Ph1b Data @ IUSTI-EU $VIR -X% First Participant Dosed for VIR-5500 Trial $QNCX -X% Present Data @ 54th CNS Mtg. $CABA -X% Rese-cel Data @ ESGCT'25 $ANVS -XX% $6M Direct Offering See the image and comments for more details" [X Link](https://x.com/BiopharmIQ/status/1976677600857887020) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-10-10T15:53Z 27.4K followers, 7921 engagements "๐ Exciting Q4 2025 BPIQ Big & Suspected Movers $IFRX Ph2a $BMEA Ph2 $ALDX Ph2 $BHVN Ph3 $ENLV Ph1/2 See our free report of stock-moving catalysts to watch in Q4. Link below" [X Link](https://x.com/BiopharmIQ/status/1976783691189043598) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-10-10T22:55Z 27.4K followers, 2146 engagements "Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q4 2025 (1/3). $LQDA Phase X $ATAI Phase 2b $EVAX Phase X $DCTH Phase X $CELC Phase X $SVRA Phase X $IDYA Phase X $IDYA Phase 2/3 $KYTX Phase X $INBX Phase X $VOR Phase X $JAGX Phase X $ALXO Phase X $PROK Phase X $VRCA Phase X $KZR Phase 2a $OSTX Phase 2b $ELDN Phase X $IFRX Phase 2a $IFRX Phase 2b $RZLT Phase X $NKTR Phase 2b $PVLA Phase X $PRAX Phase X $ASMB Phase X $RCUS Phase X $ZNTL Phase X $WVE Phase X $VALN Phase X $ROIV Phase X $RYTM Phase X $RXRX Phase X $RAPT Phase X $PRTA Phase X $PCSA Phase X $PRAX Phase 2/3 $MRUS Phase 2" [X Link](https://x.com/BiopharmIQ/status/1977473373279293714) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-10-12T20:36Z 27.4K followers, 54.6K engagements "๐งฌ Biotech Stock News 10/14 @ Open $ATXS XX% BCRX Acquires ATXS $RCKT XX% FDA Acceptance of BLA Resubmission $GNPX XX% Preclinical Data on Gene Therapy $RNAZ XX% Prelim Data from Ph1a Study $SYRE X% $275M Public Offering $TELO X% New Data on Telomir-1 and Cancer $ZYME X% Clinical Data from Ph1 Trial $AMRN X% Collaboration on REDUCE-IT Presentation $IMNN X% Ph3 Ovarian Cancer Study Presentation $TBPH X% New Analyses on YUPELRI Outcomes in COPD $TNXP X% Update on Fc-modified anti-CD40L mAb $MCRB X% Post Hoc Data from SER-155 Trial $CORT X% MAA Submitted for Relacorilant $LXRX X% Additional" [X Link](https://x.com/BiopharmIQ/status/1978129284192731545) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-10-14T16:02Z 27.4K followers, 10.9K engagements "๐งฌ Biotech Stock News 10/16 Brought to you by Barb On the rise ๐ $PRAX XXX% $MIRA XX% $CCCC XX% Under pressure ๐ $LIXT -X% $OMER -X% $TOVX -XX% Catch the full breakdown in the latest video" [X Link](https://x.com/BiopharmIQ/status/1978878464284336445) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-10-16T17:39Z 27.4K followers, 3532 engagements "๐งฌ Weekly & YTD Biotech Moves Week ending 10/17/25 $XBI: XXXX% ($107.80) ๐ข $IBB: XXXX% ($154.19) ๐ข Year-to-date $XBI: XXXXX% ๐ข $IBB: XXXXX% ๐ข See image below. ๐" [X Link](https://x.com/BiopharmIQ/status/1979316293183709191) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-10-17T22:39Z 27.4K followers, 3365 engagements "$CRNX is a BPIQ Big Mover Each quarter we identify major catalyst events Likely to move the stock +/- by XX% ๐ ๐ Get your report of stocks/catalysts to watch" [X Link](https://x.com/BiopharmIQ/status/1971608852627148885) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-09-26T16:12Z 27.4K followers, 1214 engagements "1/ ๐งต Biotech Stock News 10/07 @ Open $LXEO XX% Progress in FDA Discussions & Data $TELO XX% New Findings in Prostate Cancer Model $KZIA XX% Collaboration & In-Licensing Agreement $ANIX XX% Completion of Final Patient Visit $DBVT XX% Sale of $XX million ADSs $DYN XX% One-Year Clinical Data for DM1 $CLLS X% Data on Non-Viral Gene Therapy $OGEN X% Strategic Partnership to Accelerate Pipeline $AVIR X% New Data on Hepatitis C Treatment $ABUS X% Four Abstracts Accepted for AASLD 2025 $MAIA X% Initiate Digital Asset Treasury Strategy $GALT X% Present at AASLD Liver Meeting 2025 $EPIX 2%" [X Link](https://x.com/BiopharmIQ/status/1975591228948553946) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-10-07T15:57Z 27.4K followers, 8182 engagements "๐งฌ Biotech Stock News 10/7 Brought to you by Barb On the rise ๐ $LXEO XX% $TELO XX% $KZIA XX% Under pressure ๐ $CLRB -XX% $HUMA -XX% $BMEA -XX% Catch the full breakdown in the latest video" [X Link](https://x.com/BiopharmIQ/status/1975633731596816628) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-10-07T18:46Z 27.4K followers, 3493 engagements "๐งฌ Biotech Stock News 10/9 Brought to you by Barb On the rise ๐ $TELO XX% $AKRO XX% $NGNE XX% Under pressure ๐ $EDIT -X% $LPTX -X% $ACXP -X% Catch the full breakdown in the latest video" [X Link](https://x.com/BiopharmIQ/status/1976352625483448334) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-10-09T18:22Z 27.4K followers, 3713 engagements "๐ฐ $BMY to acquire Orbital Tx Adds OTX-201 an in vivo CAR-T Extends $BMY s cell tx into autoimmune diseases Check out our free biopharma M&A tracker: ๐ Provides info on past M&A activity" [X Link](https://x.com/BiopharmIQ/status/1976677604234314053) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-10-10T15:54Z 27.4K followers, 1316 engagements "๐ Biotech Stock News 10/13 @ Midday $CGEN XX% COM701 Pooled Analysis $RCUS X% Median OS Data in Ph2 Study $ANAB X% Late-Breaking Presentation at ACR $BCAX X% Ficerafusp Alfa Granted Breakthrough Designation $MNKD X% FDA Review for Inhaled Insulin in Youth $ADGM X% Preliminary Acute Results from FULCRUM-VT $ONC X% Sonrotoclax Breakthrough Therapy Designation $CGEM X% Present Zipalertinib Data at ESMO $HCM X% FRUSICA-2 Registration Trial Data at ESMO $NTRA X% IMvigor011 Oral Presentation at ESMO $APGE X% Closed $345M Public Offering $MRNA X% Cancer Antigen Therapy Data at ESMO $EVAX X% EVX-01" [X Link](https://x.com/BiopharmIQ/status/1977781052723884064) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-10-13T16:58Z 27.4K followers, 9238 engagements "Biotech Stock Catalyst Watchlist ๐ ๐ฏ Ph2 & Ph3 readouts in Q3 2025. $NAMS Phase 2a $CGTX Phase X $CRDF Phase X $DMAC Phase X $IXHL Phase X $ENTX Phase X $MLTX Phase X $LRMR Phase X $RAPP Phase 2a $PMVP Phase X $ATAI Phase 2b $ARCT Phase X $CLNN Phase X $AMLX Phase X $PRAX Phase 2b $ANAB Phase X $BINV Phase 2a $VYNE Phase 2b $PCSA Phase X $LSTA Phase 2a $BINV Phase 2a $INMB Phase X $LLY Phase X $ATAI Phase 2b $GRI Phase 2a $FDMT Phase X $HRMY Phase X $IONS Phase X $ENTA Phase X $KALA Phase 2b $LTRN Phase X $INBX Phase X $BTAI Phase X $PRAX Phase X $ATYR Phase X $FBIO Phase X $UPB Phase 2" [X Link](https://x.com/BiopharmIQ/status/1944458773806149859) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-07-13T18:07Z 27.4K followers, 40.1K engagements "Biotech Stock Catalyst Watchlist ๐ ๐ฏ Ph2 & Ph3 readouts in Q3 2025. $CRDL Phase X $BTAI Phase X $ENTX Phase X $CGEM Phase X $MLTX Phase X $QURE Phase 2/3 $LRMR Phase X $KAPA Phase X $RAPP Phase 2a $PMVP Phase X $ARCT Phase X $CLNN Phase X $AMLX Phase X $PRAX Phase 2b $ANAB Phase X $BINV Phase 2a $PCSA Phase X $LSTA Phase 2a $BINV Phase 2a $INMB Phase X $LLY Phase X $ATAI Phase 2b $GRI Phase 2a $HRMY Phase X $IONS Phase X $ENTA Phase X $KALA Phase 2b $LTRN Phase X $INBX Phase X $PRAX Phase X $ATYR Phase X $FBIO Phase X $UPB Phase X $ABBV Phase X $IFRX Phase 2a $IMVT Phase 2b $IFRX Phase 2b" [X Link](https://x.com/BiopharmIQ/status/1952052137510506733) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-08-03T17:01Z 27.4K followers, 331.1K engagements "๐ Biotech Stock News 8/11 @ Open ๐ $IMAB XX% Enrollment Completed in Ph1b Study $TLSA XX% Ph2 IND Approval $AMPH XX% Approval for Iron Sucrose Injection $ARVN X% NDA for Vepdegestrant Accepted $KMDA X% FDA Approval of Plasma Collection Center $INO X% INO-3107 Long-Term Surgery Reduction $NVS X% Ianalumab Ph3 Trials Met Endpoint $OCGN X% $20M Direct Offering Announced $NRXP X% Fast Track Designation for NRX-100 $BIIB X% First Patient Dosed in Ph3 Study $LGVN -X% $17.5M Public Offering $PTN -X% 1-for-50 Reverse Stock Split $VERU -X% Modified Release Oral Enobosarm for Clinical Study $IOBT" [X Link](https://x.com/BiopharmIQ/status/1954929828261712143) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-08-11T15:36Z 27.4K followers, 7242 engagements "๐งฌ Biotech Stock News 08/11 Brought to you by Barb X stocks on the rise ๐ $IMAB $TLSA $AMPH X under pressure ๐ $PTN $VERU $IOBT Catch the full breakdown in the latest video ๐ฅ" [X Link](https://x.com/BiopharmIQ/status/1954943694144163899) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-08-11T16:31Z 27.4K followers, 3640 engagements "๐ Biotech Stock News 09/17 @ Open $ROIV XX% Brepocitinib Ph3 Study Results $ORKA XX% ORKA-001 Interim Ph1 Results $ELTX X% ELI-002 Trial Update $ATXS X% Ph1a Trial Initial Results $NRIX X% Preclin Data on IRAK4 Degrader $AKTX X% New Patent Filing for ADC Platform $ARQT X% New ZORYVE Data Analyses $TNXP X% In-licensing of TNX-4800 $XFOR X% Restructuring of Business Operations $CLDX X% Barzolvolimab Data at EADV $PTGX X% PN-881 Data at EADV $CDTX X% CD388 Ph2b Data $CADL X% Ph3 Results of CAN-2409 $VTRS X% First Patient Recruited in Ph2/3 Study $REGN X% Ph2 Trial Results on GLP-1 Receptor" [X Link](https://x.com/BiopharmIQ/status/1968359434712912171) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-09-17T17:00Z 27.4K followers, 9193 engagements "1/ FGF21 showdown in MASH/NASH ๐งต $ETNB (89bio) vs $AKRO (Akero). Both pushing late-stage trials. Heres the latest" [X Link](https://x.com/BiopharmIQ/status/1968793312472576394) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-09-18T21:44Z 27.4K followers, 2197 engagements "๐ Biotech Stock News 09/26 @ Open $CRNX XX% FDA Approval of PALSONIFY for Acromegaly $GUTS XX% REMAIN-1 Midpoint Cohort Data $AMRX X% BLA Submission of Xolair Biosimilar $SNY X% Expands Patient Affordability Program $KALV X% New EKTERLY Data at Allergy Congress $CDTX X% First Participants Dosed in Ph3 Trial $KURA X% Publication of Ziftomenib Data in AML $LLY X% Marketing Authorization for Alzheimer's treatment $LLY X% FDA Approves Inluriyo for Breast Cancer $ABBV X% NDA Submission for Tavapadon $THTX X% Completion of Acquisition by Future Pak $AMGN X% $650M U.S. Manufacturing Expansion $REGN" [X Link](https://x.com/BiopharmIQ/status/1971608845396168828) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-09-26T16:12Z 27.4K followers, 7114 engagements "๐งฌ Biotech Stock News 09/26 Brought to you by Barb On the rise ๐ $CRNX XX% $GUTS XX% $AMRX X% Under pressure ๐ $AMGN -X% $REGN -X% $QURE -X% Catch the full breakdown in the latest video" [X Link](https://x.com/BiopharmIQ/status/1971640435258150937) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-09-26T18:18Z 27.4K followers, 3160 engagements "๐ Biotech Stock News 10/01 @ Open $PALI XX% Pricing of $120M Public Offering $ACOG XX% Pricing of $35M Public Offering $CPRX XX% $200M Share Repurchase Program $ARVN X% Present ARV-102 Data at MDS '25 $PHAR X% sNDA Acceptance & Priority Review for Leniolisib $AZN X% BLA Accepted for Enhertu $ILMN X% Secures $23.4M for Diagnostic Platform $TMO X% Prices Offering of Senior Notes $KURA X% Clinical Trial for AML Treatment $ADGM X% Completion of Enrollment for Trial $BMY X% Anti-Tau Antibody Granted Fast Track $ABBV X% $70M Manuf Expansion $CRSP X% Present Preclin Data on AATD at ESGCT $CCCC 2%" [X Link](https://x.com/BiopharmIQ/status/1973425159299362838) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-10-01T16:29Z 27.4K followers, 7862 engagements "๐งฌ Biotech Stock News 10/8 Brought to you by Barb On the rise ๐ $EVAX XX% $ATXS X% $SPRY X% Under pressure ๐ $VRCA -X% $RIGL -X% $ESPR -XX% Catch the full breakdown in the latest video" [X Link](https://x.com/BiopharmIQ/status/1975981170727977148) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-10-08T17:46Z 27.4K followers, 3588 engagements "๐ขM&A News: Novo Nordisk to acquire Akero Therapeutics for up to $5.2B ๐จ ๐ฐ $54/share cash + $6/share CVR tied to FDA approval of efruxifermin for MASH cirrhosis ๐ XX% premium to Akeros pre-deal price ๐งฌ Adds Phase X FGF21 analog EFX to Novos metabolic portfolio ๐ Deal closes by YE 2025 pending approvals ๐ค Signals renewed M&A momentum in MASH/NASH. Validates FGF21 pathway.potential re-rating for peers like $VKTX $TERN See image for more details" [X Link](https://x.com/BiopharmIQ/status/1976303356961550704) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-10-09T15:06Z 27.4K followers, 16K engagements "๐งฌ Biotech Weekly News - Largest single-day stock moves during the week ending 10/10/25 ๐ $SPRB 1378% Breakthrough Therapy Designation $LPTX XX% $58.88M Private Placement $LXEO XX% FDA Discussions Progress & Data $TELO XX% New Findings in Prostate CA Model $ANIX XX% Completion Final Patient Visit ๐ $SKYE -XX% Topline Ph2a Data Reported $HUMA -XX% Pricing of $XX Million Offering $BMEA -XX% 52-Wk Results in Diabetes Study $ANVS -XX% $6M Direct Offering $CABA -XX% Rese-cel Data @ ESGCT'25" [X Link](https://x.com/BiopharmIQ/status/1976780126567403630) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-10-10T22:41Z 27.4K followers, 14.1K engagements "Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q4 2025 (3/3). $ALT Phase 2b $ALEC Phase X $ADVM Phase X $ZBIO Phase X $PCVX Phase X $RARE Phase X $TRAW Phase X $GPCR Phase 2b $SLS Phase X $RHHBY Phase X $MREO Phase X $KMDA Phase X $INSM Phase X $ATOS Phase X $ARTV Phase 2a $ALZN Phase X $AGIO Phase X $ADCT Phase X $TLPH Phase X $STOK Phase X $RLMD Phase X $REGN Phase 2/3 $PBYI Phase X $PBYI Phase X $NVS Phase X $NAMS Phase X $NAMS Phase X $NAMS Phase X $MRNA Phase X $INKT Phase X $LSTA Phase 2b $KZIA Phase X $JAZZ Phase X $IONS Phase X $INAB Phase X $IMMP Phase 2/3 $GNFT Phase X $FBIO" [X Link](https://x.com/BiopharmIQ/status/1977473383878230508) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-10-12T20:36Z 27.4K followers, XXX engagements "๐ข M&A News: BioCryst $BCRX to Acquire Astria Therapeutics $ATXS ๐ต Cash-and-stock deal valued at about $700m ๐ $13/sh (53% premium over ATXS last close) ๐ Adds navenibart long-acting injectable for HAE currently in Ph3 ๐ค To close in Q1 2026 See image for more info ๐" [X Link](https://x.com/BiopharmIQ/status/1978111044066111699) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-10-14T14:49Z 27.4K followers, 5357 engagements "BioCryst $BCRX to Acquire Astria Therapeutics $ATXS ๐" [X Link](https://x.com/BiopharmIQ/status/1978129289838280936) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-10-14T16:02Z 27.4K followers, 2204 engagements "๐งฌ Biotech Weekly News 05/05/25 - 05/09/25 Major Movers ๐ ๐ $IMMP XX% Efti with KEYTRUDA OS Data $CRVS XX% Soquelitinib Ph1 Trial Data $TLSA XX% Positive Results Nasal Foralumab Study $PHIO XX% Positive Results in PH-762 Trial $ALGS XX% Positive Data at EASL Congress 2025 $NCNA -XX% $X Million Direct Offering $PTN -XX% MELODY-1 Trial Data @ ARVO'25 $ALDX -XX% Achieves Primary Endpoint in Trial $OSTX -XX% U.S. Patent Issued for OST-HER2 $CGTX -XX% Ph2 Topline Results in GA See image below. ๐ธ ๐" [X Link](https://x.com/BiopharmIQ/status/1920965732768378894) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-05-09T22:14Z 27.4K followers, 5286 engagements "๐ Biotech Stock News 10/08 @ Open $EVAX XX% Expands AI-Immunology Platform $ATXS X% Navenibart Ph3 Trial Initiation $SPRY X% Favorable Patent Decision on neffy $LSTA X% Global ADC License Agreement $AARD X% FDA Alignment on Protocol Amendment $TRVI X% Oral Presentation at CHEST 2025 $AQST X% Broadens Patent Estate for Anaphylm $HOWL X% Fast Track Designation for WTX-124 $OSTX -X% Participation in Fall 2025 Conferences $IVA -X% Presenting Multiple Abstracts at AASLD $ZBIO -X% License Agreement for Autoimmune Candidates $VRCA -X% New Data on VP-315 for BCC $RIGL -X% First Patient Enrolled in" [X Link](https://x.com/BiopharmIQ/status/1975950592465072591) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-10-08T15:45Z 27.4K followers, 7821 engagements "๐งฌ Biotech Stock News 10/14 Brought to you by Barb On the rise ๐ $ATXS XX% $RCKT XX% $GNPX XX% Under pressure ๐ $NCNA -X% $VOR -X% $CADL -XX% Catch the full breakdown in the latest video" [X Link](https://x.com/BiopharmIQ/status/1978155644613263551) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-10-14T17:47Z 27.4K followers, 4015 engagements "๐ Biotech Stock News 07/30 ๐งฌ ๐ฝ $VRDN XX% Collaboration & License Agreement w/ Kissei Pharma $IMNN X% First Patient Dosed in Ph3 Study $CELC X% Pricing of Public Offering $MIRA X% Topical Ketamir-2 Preclin Data $ACRS X% Results from ATI-2138 Ph2a Trial $CRBP X% CRB- XXX Ph1/2 Clinical Data at ESMO $TNYA X% Safety Reviews for Gene Trials $LRMR X% Pricing of Public Offering $ABBV X% Ph3 Topline Results from Alopecia Trial $BIIB X% New Data on Leqembi at AAIC $NAMS X% Data from BROADWAY Trial at AAIC $SNSE X% Clinical Data from Phase X Cohort at ESMO $MDGL X% Exclusive Global License for GLP-1" [X Link](https://x.com/BiopharmIQ/status/1950670171124953346) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-07-30T21:29Z 27.4K followers, 3544 engagements "1/ ๐ฃ Biotech Stock News 09/02 @ Midday $UTHR XX% TETON-2 Study Meets Primary Endpoint $CYTK XX% New Data on Aficamten Presented $IONS XX% Olezarsen Landmark Trials Results $ARWR XX% Global License and Collaboration Agreement $REPL X% Type A Meeting Scheduled with FDA $UPB X% Positive Results from Phase X Trial $OLMA X% New Clinical Trial for Breast Cancer $ZBIO X% Obexelimab Funding Agreement for $300M $VTVT X% $XX Million Private Placement Announced $OMER X% Publication on Survival Outcomes in TA-TMA $LXRX X% Risk Reduction in Heart Failure Data $BIIB X% Data Support Zorevunersen for Dravet" [X Link](https://x.com/BiopharmIQ/status/1962925451627921445) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-09-02T17:07Z 27.4K followers, 8989 engagements "๐งฌ Biotech Weekly News 9/2/25 - 9/5/25 Major Movers ๐ $CYTK XX% Presented New Aficamten Data $IONS XX% Olezarsen Landmark Trials Results $UTHR XX% TETON-2 Study Met Endpoint $AQST XX% FDA Will Not Require AdCom $OLMA XX% New Trial for Breast Cancer ๐ $WVE -XX% RestorAATion-2 Trial Update $THAR -XX% Presentations on TH104 $PMN -XX% DSMB Approval for Ph1b Trial $AGIO -XX% Update on PDUFA Goal Date $MBX -XX% Doses First Patient in Ph1 ****** X asset. Multiple shots on goal ๐ $CYTK aficamten looks like the rare true pipeline-in-a-pill A franchise play unfolding fast. Dont miss @BowTiedBiotechs" [X Link](https://x.com/BiopharmIQ/status/1964100577199276158) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-09-05T22:57Z 27.4K followers, 13.7K engagements "Biotech Stock Catalyst Watchlist ๐ฏ Ph2 & Ph3 readouts in Q3 2025. $UTHR Phase X $ARCT Phase X $MLTX Phase X $QURE Phase 2/3 $ENTA Phase X $KALA Phase 2b $LTRN Phase X $LRMR Phase X $ENTX Phase X $MTSR Phase 2b $ATAI Phase 2b $GRI Phase 2a $HRMY Phase X $CLNN Phase X $NKTR Phase X $FBIO Phase X $LGVN Phase 2a $SKYE Phase 2a $PRAX Phase X Check out the image for more details" [X Link](https://x.com/BiopharmIQ/status/1969840377307017587) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-09-21T19:05Z 27.4K followers, 52.4K engagements "Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q4 2025 (1/3). $LQDA Phase X $IFRX Phase 2a $IFRX Phase 2b $PTGX Phase 2b $EVAX Phase X $DCTH Phase X $CELC Phase X $IDYA Phase X $IDYA Phase 2/3 $KYTX Phase X $VOR Phase X $ATAI Phase 2b $INBX Phase X $KZR Phase 2a $PROK Phase X $ELDN Phase X $PVLA Phase X $NKTR Phase 2b $RZLT Phase X $RCUS Phase X $ASMB Phase X $BDTX Phase X $RNA Phase X $CAPR Phase X $TARA Phase X $ZVSA Phase 2a $CGON Phase X $VTYX Phase X $DBVT Phase X $PHVS Phase X $VTGN Phase X $TERN Phase X $ALEC Phase X $ZBIO Phase X $IRON Phase X $INBX Phase 2/3 $MLTX Phase 2" [X Link](https://x.com/BiopharmIQ/status/1972384105515176360) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-09-28T19:33Z 27.4K followers, 41K engagements "Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q4 2025 (2/3). $ARGX Phase X $INCY Phase X $WVE Phase X $EWTX Phase X $RNAC Phase X $ROIV Phase X $GLPG Phase X $MGNX Phase X $BHVN Phase X $ANRO Phase X $PRAX Phase 2/3 $BHVN Phase X $COGT Phase X $ALKS Phase X $MRUS Phase X $MRUS Phase X $MRUS Phase X $ZNTL Phase X $IOVA Phase X $IOVA Phase X $AVXL Phase X $BBIO Phase X $GNLX Phase X $COYA Phase X $RXRX Phase X $PRTA Phase X $VALN Phase X $CGON Phase X $GNLX Phase X $EXEL Phase X $COGT Phase X $PCSA Phase X $IMVT Phase X $BMEA Phase X $EXEL Phase X $JAZZ Phase X $HOOK Phase X $ANRO" [X Link](https://x.com/BiopharmIQ/status/1972384110913208608) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-09-28T19:33Z 27.4K followers, XXX engagements "October Biotech PDUFA Pulse: ๐ก Whats on the FDA Radar $JAZZ - Zepzelca + Tecentriq - Approved $ARQT - ZORYVE (roflumilast) Cream XXXX% $AMGN - Tezspire $GKOS - Epioxa (Epi-on) $GSK - Blenrep combinations (BVd & BPd) $SNDX - Revuforj (revumenib) $MRK - WINREVAIR (sotatercept-csrk) $RHHBY - Gazyva/Gazyvaro $REGN - Libtayo (cemiplimab) Check out this months PDUFA calendar" [X Link](https://x.com/BiopharmIQ/status/1974145025824145470) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-10-03T16:10Z 27.4K followers, 17.7K engagements "๐ฃ Biotech Stock News 10/15 @ Open $OMER XXX% Asset purchase & license agreement $APLM XX% Resumes Trading $SPRC XX% Acquisition Agreement $ABSI XX% KOL Seminar on ABS-201 Program $XNCR X% Ph1 Dose-Escalation Results Presented $GYRE X% Completion of Patient Enrollment in Trial $SCYX X% Disagreement Resolved on Phase X Study $NVCR X% New Research for TTFields Therapy $HIMS X% Launches Menopause & Perimenopause Specialty $TEM X% Six Abstracts Accepted for ESMO 2025 $MNPR X% Abstract Accepted for Oral Presentation $ACOG X% Presenting Clinical Data at Meetings $AUPH X% Upcoming Presentations on" [X Link](https://x.com/BiopharmIQ/status/1978486736369123644) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-10-15T15:42Z 27.4K followers, 9614 engagements "๐งฌ Biotech Stock News 10/15 Brought to you by Barb On the rise ๐ $OMER XXX% $APLM XX% $SPRC XX% Under pressure ๐ $KROS -X% $EYPT -X% $AKTX -XX% Catch the full breakdown in the latest video" [X Link](https://x.com/BiopharmIQ/status/1978513110827761733) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-10-15T17:27Z 27.4K followers, 3746 engagements "๐ฃ Biotech Stock News 10/16 @ Open $PRAX XXX% Positive Topline Results Ph3 Studies $MIRA XX% Oral Mira-55 Outperforms Injected Morphine $CCCC XX% Pricing of $125M Offering $ANVS XX% Closing of $X Million Offering $GRAL XX% Strategic Collaboration for Multi-Cancer Test $PSNL XX% New Data from Lung Cancer Trial $NXTC XX% Expansion of Phase X Trial $CLLS XX% Hosts R&D Day Showcasing Pipeline $APLM X% Continued Nasdaq Listing After Hearing $VTGN X% Present at Menopause Society Annual Meeting $CTXR X% Exclusive Commercialization Agreement for LYMPHIR $ACET X% First Patient Dosed in Phase X Trial" [X Link](https://x.com/BiopharmIQ/status/1978856816261144833) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-10-16T16:13Z 27.4K followers, 8475 engagements "Try BPIQ API Free Get catalyst & pipeline data integrate seamlessly craft custom spreadsheets. ๐ Premium API access unlocks - full platform access - updated catalysts/pipeline data - & historical data for robust testing Check link below" [X Link](https://x.com/BiopharmIQ/status/1979318851755217123) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-10-17T22:49Z 27.4K followers, 1392 engagements "๐งฌ Biopharma Weekly Recap ๐ This week in biotech: Gene therapy and CRISPR roar back as $QURE M&A chatter heats up $NTLA leads in vivo race institutional money piles into GLP-1 giants and $XBIs rally signals sector revival. See interesting posts/ppl to check out ๐ @ericjackson ๐ Rate Cuts. Risk On. Biotech Reawakens. $SANA Looks Like the Next 100-Bagger Platform. @yaireinhorn BioTech & Pharma rebound: $XBI +9.5% since Sept XX +16.6% YTD. Recovery looks real but IPOs will be the true test. @mikeaxolotl Thesis: $QURE will be acquired for $8.5-11.4B+ within 6-18 months. That's 138-200%+ upside" [X Link](https://x.com/BiopharmIQ/status/1979539567184347239) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-10-18T13:26Z 27.4K followers, 12K engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@BiopharmIQ
"Biotech Stock Catalyst Watchlist ๐ฏ Ph2 & Ph3 readouts in Q3 2025. $TRML Phase X $CGEM Phase X $PMVP Phase X $IMVT Phase X $ATYR Phase X $ARCT Phase X $IONS Phase X $MLTX Phase X $QURE Phase 2/3 $ENTA Phase X $KALA Phase 2b $LTRN Phase X $LRMR Phase X $ENTX Phase X $KAPA Phase X $RAPP Phase 2a $MTSR Phase 2b $PRAX Phase X $ATAI Phase 2b $GRI Phase 2a $HRMY Phase X $CLNN Phase X $FBIO Phase X $UPB Phase X $LGVN Phase 2a $SKYE Phase 2a Check out the image for more details"
X Link @BiopharmIQ 2025-08-31T16:41Z 27.4K followers, 48K engagements
"๐ข M&A News: Genmab $GMAB to acquire Merus $MRUS for $8B ๐ฐ $97/share all-cash (41% premium $8B EV) ๐งฌ Adds Phase X bispecific petosemtamab (BTD in head & neck cancer) Ph2 data showed strong ORR & PFS SOC; Ph3 readouts in 2026 Expected launch 2027 $1B sales by 2029 multi-billion potential longer term ๐ Closing by Q1 2026 See photo for more info ๐"
X Link @BiopharmIQ 2025-09-29T14:40Z 27.4K followers, 10.4K engagements
"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q4 2025 (1/3). $PTGX Phase 2b $EVAX Phase X $DCTH Phase X $CELC Phase X $IDYA Phase X $IDYA Phase 2/3 $KYTX Phase X $VOR Phase X $INBX Phase X $ATAI Phase 2b $LQDA Phase X $PROK Phase X $KZR Phase 2a $ALXO Phase X $ELDN Phase X $IFRX Phase 2a $IFRX Phase 2b $NKTR Phase 2b $RZLT Phase X $PVLA Phase X $BDTX Phase X $RNA Phase X $CAPR Phase X $TARA Phase X $ZVSA Phase 2a $CGON Phase X $VTYX Phase X $DBVT Phase X $PHVS Phase X $VTGN Phase X $TERN Phase X $ALEC Phase X $ZBIO Phase X $IRON Phase X $INBX Phase 2/3 $MLTX Phase X $ANAB Phase 2"
X Link @BiopharmIQ 2025-10-05T20:24Z 27.4K followers, 55.3K engagements
"๐ Biotech Stock News 10/10 @ Open $CDTX X% Present @ 10th ESWI Influenza Conf. $AZN X% Expand VA Manuf. Facility $OSTX X% OST-HER2 Ph2b OS Data $JNJ X% MDD Portfolio @ 2025 ECNP Congress $CRSP X% New Preclinical CTX460 Data $BIIB -X% New Zorevunersen Data @ 54th CNS Mtg. $BMY -X% To Acquire Orbital Therapeutics $ASMB -X% ABI-5366 Interim Ph1b Data @ IUSTI-EU $VIR -X% First Participant Dosed for VIR-5500 Trial $QNCX -X% Present Data @ 54th CNS Mtg. $CABA -X% Rese-cel Data @ ESGCT'25 $ANVS -XX% $6M Direct Offering See the image and comments for more details"
X Link @BiopharmIQ 2025-10-10T15:53Z 27.4K followers, 7921 engagements
"๐ Exciting Q4 2025 BPIQ Big & Suspected Movers $IFRX Ph2a $BMEA Ph2 $ALDX Ph2 $BHVN Ph3 $ENLV Ph1/2 See our free report of stock-moving catalysts to watch in Q4. Link below"
X Link @BiopharmIQ 2025-10-10T22:55Z 27.4K followers, 2146 engagements
"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q4 2025 (1/3). $LQDA Phase X $ATAI Phase 2b $EVAX Phase X $DCTH Phase X $CELC Phase X $SVRA Phase X $IDYA Phase X $IDYA Phase 2/3 $KYTX Phase X $INBX Phase X $VOR Phase X $JAGX Phase X $ALXO Phase X $PROK Phase X $VRCA Phase X $KZR Phase 2a $OSTX Phase 2b $ELDN Phase X $IFRX Phase 2a $IFRX Phase 2b $RZLT Phase X $NKTR Phase 2b $PVLA Phase X $PRAX Phase X $ASMB Phase X $RCUS Phase X $ZNTL Phase X $WVE Phase X $VALN Phase X $ROIV Phase X $RYTM Phase X $RXRX Phase X $RAPT Phase X $PRTA Phase X $PCSA Phase X $PRAX Phase 2/3 $MRUS Phase 2"
X Link @BiopharmIQ 2025-10-12T20:36Z 27.4K followers, 54.6K engagements
"๐งฌ Biotech Stock News 10/14 @ Open $ATXS XX% BCRX Acquires ATXS $RCKT XX% FDA Acceptance of BLA Resubmission $GNPX XX% Preclinical Data on Gene Therapy $RNAZ XX% Prelim Data from Ph1a Study $SYRE X% $275M Public Offering $TELO X% New Data on Telomir-1 and Cancer $ZYME X% Clinical Data from Ph1 Trial $AMRN X% Collaboration on REDUCE-IT Presentation $IMNN X% Ph3 Ovarian Cancer Study Presentation $TBPH X% New Analyses on YUPELRI Outcomes in COPD $TNXP X% Update on Fc-modified anti-CD40L mAb $MCRB X% Post Hoc Data from SER-155 Trial $CORT X% MAA Submitted for Relacorilant $LXRX X% Additional"
X Link @BiopharmIQ 2025-10-14T16:02Z 27.4K followers, 10.9K engagements
"๐งฌ Biotech Stock News 10/16 Brought to you by Barb On the rise ๐ $PRAX XXX% $MIRA XX% $CCCC XX% Under pressure ๐ $LIXT -X% $OMER -X% $TOVX -XX% Catch the full breakdown in the latest video"
X Link @BiopharmIQ 2025-10-16T17:39Z 27.4K followers, 3532 engagements
"๐งฌ Weekly & YTD Biotech Moves Week ending 10/17/25 $XBI: XXXX% ($107.80) ๐ข $IBB: XXXX% ($154.19) ๐ข Year-to-date $XBI: XXXXX% ๐ข $IBB: XXXXX% ๐ข See image below. ๐"
X Link @BiopharmIQ 2025-10-17T22:39Z 27.4K followers, 3365 engagements
"$CRNX is a BPIQ Big Mover Each quarter we identify major catalyst events Likely to move the stock +/- by XX% ๐ ๐ Get your report of stocks/catalysts to watch"
X Link @BiopharmIQ 2025-09-26T16:12Z 27.4K followers, 1214 engagements
"1/ ๐งต Biotech Stock News 10/07 @ Open $LXEO XX% Progress in FDA Discussions & Data $TELO XX% New Findings in Prostate Cancer Model $KZIA XX% Collaboration & In-Licensing Agreement $ANIX XX% Completion of Final Patient Visit $DBVT XX% Sale of $XX million ADSs $DYN XX% One-Year Clinical Data for DM1 $CLLS X% Data on Non-Viral Gene Therapy $OGEN X% Strategic Partnership to Accelerate Pipeline $AVIR X% New Data on Hepatitis C Treatment $ABUS X% Four Abstracts Accepted for AASLD 2025 $MAIA X% Initiate Digital Asset Treasury Strategy $GALT X% Present at AASLD Liver Meeting 2025 $EPIX 2%"
X Link @BiopharmIQ 2025-10-07T15:57Z 27.4K followers, 8182 engagements
"๐งฌ Biotech Stock News 10/7 Brought to you by Barb On the rise ๐ $LXEO XX% $TELO XX% $KZIA XX% Under pressure ๐ $CLRB -XX% $HUMA -XX% $BMEA -XX% Catch the full breakdown in the latest video"
X Link @BiopharmIQ 2025-10-07T18:46Z 27.4K followers, 3493 engagements
"๐งฌ Biotech Stock News 10/9 Brought to you by Barb On the rise ๐ $TELO XX% $AKRO XX% $NGNE XX% Under pressure ๐ $EDIT -X% $LPTX -X% $ACXP -X% Catch the full breakdown in the latest video"
X Link @BiopharmIQ 2025-10-09T18:22Z 27.4K followers, 3713 engagements
"๐ฐ $BMY to acquire Orbital Tx Adds OTX-201 an in vivo CAR-T Extends $BMY s cell tx into autoimmune diseases Check out our free biopharma M&A tracker: ๐ Provides info on past M&A activity"
X Link @BiopharmIQ 2025-10-10T15:54Z 27.4K followers, 1316 engagements
"๐ Biotech Stock News 10/13 @ Midday $CGEN XX% COM701 Pooled Analysis $RCUS X% Median OS Data in Ph2 Study $ANAB X% Late-Breaking Presentation at ACR $BCAX X% Ficerafusp Alfa Granted Breakthrough Designation $MNKD X% FDA Review for Inhaled Insulin in Youth $ADGM X% Preliminary Acute Results from FULCRUM-VT $ONC X% Sonrotoclax Breakthrough Therapy Designation $CGEM X% Present Zipalertinib Data at ESMO $HCM X% FRUSICA-2 Registration Trial Data at ESMO $NTRA X% IMvigor011 Oral Presentation at ESMO $APGE X% Closed $345M Public Offering $MRNA X% Cancer Antigen Therapy Data at ESMO $EVAX X% EVX-01"
X Link @BiopharmIQ 2025-10-13T16:58Z 27.4K followers, 9238 engagements
"Biotech Stock Catalyst Watchlist ๐ ๐ฏ Ph2 & Ph3 readouts in Q3 2025. $NAMS Phase 2a $CGTX Phase X $CRDF Phase X $DMAC Phase X $IXHL Phase X $ENTX Phase X $MLTX Phase X $LRMR Phase X $RAPP Phase 2a $PMVP Phase X $ATAI Phase 2b $ARCT Phase X $CLNN Phase X $AMLX Phase X $PRAX Phase 2b $ANAB Phase X $BINV Phase 2a $VYNE Phase 2b $PCSA Phase X $LSTA Phase 2a $BINV Phase 2a $INMB Phase X $LLY Phase X $ATAI Phase 2b $GRI Phase 2a $FDMT Phase X $HRMY Phase X $IONS Phase X $ENTA Phase X $KALA Phase 2b $LTRN Phase X $INBX Phase X $BTAI Phase X $PRAX Phase X $ATYR Phase X $FBIO Phase X $UPB Phase 2"
X Link @BiopharmIQ 2025-07-13T18:07Z 27.4K followers, 40.1K engagements
"Biotech Stock Catalyst Watchlist ๐ ๐ฏ Ph2 & Ph3 readouts in Q3 2025. $CRDL Phase X $BTAI Phase X $ENTX Phase X $CGEM Phase X $MLTX Phase X $QURE Phase 2/3 $LRMR Phase X $KAPA Phase X $RAPP Phase 2a $PMVP Phase X $ARCT Phase X $CLNN Phase X $AMLX Phase X $PRAX Phase 2b $ANAB Phase X $BINV Phase 2a $PCSA Phase X $LSTA Phase 2a $BINV Phase 2a $INMB Phase X $LLY Phase X $ATAI Phase 2b $GRI Phase 2a $HRMY Phase X $IONS Phase X $ENTA Phase X $KALA Phase 2b $LTRN Phase X $INBX Phase X $PRAX Phase X $ATYR Phase X $FBIO Phase X $UPB Phase X $ABBV Phase X $IFRX Phase 2a $IMVT Phase 2b $IFRX Phase 2b"
X Link @BiopharmIQ 2025-08-03T17:01Z 27.4K followers, 331.1K engagements
"๐ Biotech Stock News 8/11 @ Open ๐ $IMAB XX% Enrollment Completed in Ph1b Study $TLSA XX% Ph2 IND Approval $AMPH XX% Approval for Iron Sucrose Injection $ARVN X% NDA for Vepdegestrant Accepted $KMDA X% FDA Approval of Plasma Collection Center $INO X% INO-3107 Long-Term Surgery Reduction $NVS X% Ianalumab Ph3 Trials Met Endpoint $OCGN X% $20M Direct Offering Announced $NRXP X% Fast Track Designation for NRX-100 $BIIB X% First Patient Dosed in Ph3 Study $LGVN -X% $17.5M Public Offering $PTN -X% 1-for-50 Reverse Stock Split $VERU -X% Modified Release Oral Enobosarm for Clinical Study $IOBT"
X Link @BiopharmIQ 2025-08-11T15:36Z 27.4K followers, 7242 engagements
"๐งฌ Biotech Stock News 08/11 Brought to you by Barb X stocks on the rise ๐ $IMAB $TLSA $AMPH X under pressure ๐ $PTN $VERU $IOBT Catch the full breakdown in the latest video ๐ฅ"
X Link @BiopharmIQ 2025-08-11T16:31Z 27.4K followers, 3640 engagements
"๐ Biotech Stock News 09/17 @ Open $ROIV XX% Brepocitinib Ph3 Study Results $ORKA XX% ORKA-001 Interim Ph1 Results $ELTX X% ELI-002 Trial Update $ATXS X% Ph1a Trial Initial Results $NRIX X% Preclin Data on IRAK4 Degrader $AKTX X% New Patent Filing for ADC Platform $ARQT X% New ZORYVE Data Analyses $TNXP X% In-licensing of TNX-4800 $XFOR X% Restructuring of Business Operations $CLDX X% Barzolvolimab Data at EADV $PTGX X% PN-881 Data at EADV $CDTX X% CD388 Ph2b Data $CADL X% Ph3 Results of CAN-2409 $VTRS X% First Patient Recruited in Ph2/3 Study $REGN X% Ph2 Trial Results on GLP-1 Receptor"
X Link @BiopharmIQ 2025-09-17T17:00Z 27.4K followers, 9193 engagements
"1/ FGF21 showdown in MASH/NASH ๐งต $ETNB (89bio) vs $AKRO (Akero). Both pushing late-stage trials. Heres the latest"
X Link @BiopharmIQ 2025-09-18T21:44Z 27.4K followers, 2197 engagements
"๐ Biotech Stock News 09/26 @ Open $CRNX XX% FDA Approval of PALSONIFY for Acromegaly $GUTS XX% REMAIN-1 Midpoint Cohort Data $AMRX X% BLA Submission of Xolair Biosimilar $SNY X% Expands Patient Affordability Program $KALV X% New EKTERLY Data at Allergy Congress $CDTX X% First Participants Dosed in Ph3 Trial $KURA X% Publication of Ziftomenib Data in AML $LLY X% Marketing Authorization for Alzheimer's treatment $LLY X% FDA Approves Inluriyo for Breast Cancer $ABBV X% NDA Submission for Tavapadon $THTX X% Completion of Acquisition by Future Pak $AMGN X% $650M U.S. Manufacturing Expansion $REGN"
X Link @BiopharmIQ 2025-09-26T16:12Z 27.4K followers, 7114 engagements
"๐งฌ Biotech Stock News 09/26 Brought to you by Barb On the rise ๐ $CRNX XX% $GUTS XX% $AMRX X% Under pressure ๐ $AMGN -X% $REGN -X% $QURE -X% Catch the full breakdown in the latest video"
X Link @BiopharmIQ 2025-09-26T18:18Z 27.4K followers, 3160 engagements
"๐ Biotech Stock News 10/01 @ Open $PALI XX% Pricing of $120M Public Offering $ACOG XX% Pricing of $35M Public Offering $CPRX XX% $200M Share Repurchase Program $ARVN X% Present ARV-102 Data at MDS '25 $PHAR X% sNDA Acceptance & Priority Review for Leniolisib $AZN X% BLA Accepted for Enhertu $ILMN X% Secures $23.4M for Diagnostic Platform $TMO X% Prices Offering of Senior Notes $KURA X% Clinical Trial for AML Treatment $ADGM X% Completion of Enrollment for Trial $BMY X% Anti-Tau Antibody Granted Fast Track $ABBV X% $70M Manuf Expansion $CRSP X% Present Preclin Data on AATD at ESGCT $CCCC 2%"
X Link @BiopharmIQ 2025-10-01T16:29Z 27.4K followers, 7862 engagements
"๐งฌ Biotech Stock News 10/8 Brought to you by Barb On the rise ๐ $EVAX XX% $ATXS X% $SPRY X% Under pressure ๐ $VRCA -X% $RIGL -X% $ESPR -XX% Catch the full breakdown in the latest video"
X Link @BiopharmIQ 2025-10-08T17:46Z 27.4K followers, 3588 engagements
"๐ขM&A News: Novo Nordisk to acquire Akero Therapeutics for up to $5.2B ๐จ ๐ฐ $54/share cash + $6/share CVR tied to FDA approval of efruxifermin for MASH cirrhosis ๐ XX% premium to Akeros pre-deal price ๐งฌ Adds Phase X FGF21 analog EFX to Novos metabolic portfolio ๐ Deal closes by YE 2025 pending approvals ๐ค Signals renewed M&A momentum in MASH/NASH. Validates FGF21 pathway.potential re-rating for peers like $VKTX $TERN See image for more details"
X Link @BiopharmIQ 2025-10-09T15:06Z 27.4K followers, 16K engagements
"๐งฌ Biotech Weekly News - Largest single-day stock moves during the week ending 10/10/25 ๐ $SPRB 1378% Breakthrough Therapy Designation $LPTX XX% $58.88M Private Placement $LXEO XX% FDA Discussions Progress & Data $TELO XX% New Findings in Prostate CA Model $ANIX XX% Completion Final Patient Visit ๐ $SKYE -XX% Topline Ph2a Data Reported $HUMA -XX% Pricing of $XX Million Offering $BMEA -XX% 52-Wk Results in Diabetes Study $ANVS -XX% $6M Direct Offering $CABA -XX% Rese-cel Data @ ESGCT'25"
X Link @BiopharmIQ 2025-10-10T22:41Z 27.4K followers, 14.1K engagements
"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q4 2025 (3/3). $ALT Phase 2b $ALEC Phase X $ADVM Phase X $ZBIO Phase X $PCVX Phase X $RARE Phase X $TRAW Phase X $GPCR Phase 2b $SLS Phase X $RHHBY Phase X $MREO Phase X $KMDA Phase X $INSM Phase X $ATOS Phase X $ARTV Phase 2a $ALZN Phase X $AGIO Phase X $ADCT Phase X $TLPH Phase X $STOK Phase X $RLMD Phase X $REGN Phase 2/3 $PBYI Phase X $PBYI Phase X $NVS Phase X $NAMS Phase X $NAMS Phase X $NAMS Phase X $MRNA Phase X $INKT Phase X $LSTA Phase 2b $KZIA Phase X $JAZZ Phase X $IONS Phase X $INAB Phase X $IMMP Phase 2/3 $GNFT Phase X $FBIO"
X Link @BiopharmIQ 2025-10-12T20:36Z 27.4K followers, XXX engagements
"๐ข M&A News: BioCryst $BCRX to Acquire Astria Therapeutics $ATXS ๐ต Cash-and-stock deal valued at about $700m ๐ $13/sh (53% premium over ATXS last close) ๐ Adds navenibart long-acting injectable for HAE currently in Ph3 ๐ค To close in Q1 2026 See image for more info ๐"
X Link @BiopharmIQ 2025-10-14T14:49Z 27.4K followers, 5357 engagements
"BioCryst $BCRX to Acquire Astria Therapeutics $ATXS ๐"
X Link @BiopharmIQ 2025-10-14T16:02Z 27.4K followers, 2204 engagements
"๐งฌ Biotech Weekly News 05/05/25 - 05/09/25 Major Movers ๐ ๐ $IMMP XX% Efti with KEYTRUDA OS Data $CRVS XX% Soquelitinib Ph1 Trial Data $TLSA XX% Positive Results Nasal Foralumab Study $PHIO XX% Positive Results in PH-762 Trial $ALGS XX% Positive Data at EASL Congress 2025 $NCNA -XX% $X Million Direct Offering $PTN -XX% MELODY-1 Trial Data @ ARVO'25 $ALDX -XX% Achieves Primary Endpoint in Trial $OSTX -XX% U.S. Patent Issued for OST-HER2 $CGTX -XX% Ph2 Topline Results in GA See image below. ๐ธ ๐"
X Link @BiopharmIQ 2025-05-09T22:14Z 27.4K followers, 5286 engagements
"๐ Biotech Stock News 10/08 @ Open $EVAX XX% Expands AI-Immunology Platform $ATXS X% Navenibart Ph3 Trial Initiation $SPRY X% Favorable Patent Decision on neffy $LSTA X% Global ADC License Agreement $AARD X% FDA Alignment on Protocol Amendment $TRVI X% Oral Presentation at CHEST 2025 $AQST X% Broadens Patent Estate for Anaphylm $HOWL X% Fast Track Designation for WTX-124 $OSTX -X% Participation in Fall 2025 Conferences $IVA -X% Presenting Multiple Abstracts at AASLD $ZBIO -X% License Agreement for Autoimmune Candidates $VRCA -X% New Data on VP-315 for BCC $RIGL -X% First Patient Enrolled in"
X Link @BiopharmIQ 2025-10-08T15:45Z 27.4K followers, 7821 engagements
"๐งฌ Biotech Stock News 10/14 Brought to you by Barb On the rise ๐ $ATXS XX% $RCKT XX% $GNPX XX% Under pressure ๐ $NCNA -X% $VOR -X% $CADL -XX% Catch the full breakdown in the latest video"
X Link @BiopharmIQ 2025-10-14T17:47Z 27.4K followers, 4015 engagements
"๐ Biotech Stock News 07/30 ๐งฌ ๐ฝ $VRDN XX% Collaboration & License Agreement w/ Kissei Pharma $IMNN X% First Patient Dosed in Ph3 Study $CELC X% Pricing of Public Offering $MIRA X% Topical Ketamir-2 Preclin Data $ACRS X% Results from ATI-2138 Ph2a Trial $CRBP X% CRB- XXX Ph1/2 Clinical Data at ESMO $TNYA X% Safety Reviews for Gene Trials $LRMR X% Pricing of Public Offering $ABBV X% Ph3 Topline Results from Alopecia Trial $BIIB X% New Data on Leqembi at AAIC $NAMS X% Data from BROADWAY Trial at AAIC $SNSE X% Clinical Data from Phase X Cohort at ESMO $MDGL X% Exclusive Global License for GLP-1"
X Link @BiopharmIQ 2025-07-30T21:29Z 27.4K followers, 3544 engagements
"1/ ๐ฃ Biotech Stock News 09/02 @ Midday $UTHR XX% TETON-2 Study Meets Primary Endpoint $CYTK XX% New Data on Aficamten Presented $IONS XX% Olezarsen Landmark Trials Results $ARWR XX% Global License and Collaboration Agreement $REPL X% Type A Meeting Scheduled with FDA $UPB X% Positive Results from Phase X Trial $OLMA X% New Clinical Trial for Breast Cancer $ZBIO X% Obexelimab Funding Agreement for $300M $VTVT X% $XX Million Private Placement Announced $OMER X% Publication on Survival Outcomes in TA-TMA $LXRX X% Risk Reduction in Heart Failure Data $BIIB X% Data Support Zorevunersen for Dravet"
X Link @BiopharmIQ 2025-09-02T17:07Z 27.4K followers, 8989 engagements
"๐งฌ Biotech Weekly News 9/2/25 - 9/5/25 Major Movers ๐ $CYTK XX% Presented New Aficamten Data $IONS XX% Olezarsen Landmark Trials Results $UTHR XX% TETON-2 Study Met Endpoint $AQST XX% FDA Will Not Require AdCom $OLMA XX% New Trial for Breast Cancer ๐ $WVE -XX% RestorAATion-2 Trial Update $THAR -XX% Presentations on TH104 $PMN -XX% DSMB Approval for Ph1b Trial $AGIO -XX% Update on PDUFA Goal Date $MBX -XX% Doses First Patient in Ph1 ****** X asset. Multiple shots on goal ๐ $CYTK aficamten looks like the rare true pipeline-in-a-pill A franchise play unfolding fast. Dont miss @BowTiedBiotechs"
X Link @BiopharmIQ 2025-09-05T22:57Z 27.4K followers, 13.7K engagements
"Biotech Stock Catalyst Watchlist ๐ฏ Ph2 & Ph3 readouts in Q3 2025. $UTHR Phase X $ARCT Phase X $MLTX Phase X $QURE Phase 2/3 $ENTA Phase X $KALA Phase 2b $LTRN Phase X $LRMR Phase X $ENTX Phase X $MTSR Phase 2b $ATAI Phase 2b $GRI Phase 2a $HRMY Phase X $CLNN Phase X $NKTR Phase X $FBIO Phase X $LGVN Phase 2a $SKYE Phase 2a $PRAX Phase X Check out the image for more details"
X Link @BiopharmIQ 2025-09-21T19:05Z 27.4K followers, 52.4K engagements
"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q4 2025 (1/3). $LQDA Phase X $IFRX Phase 2a $IFRX Phase 2b $PTGX Phase 2b $EVAX Phase X $DCTH Phase X $CELC Phase X $IDYA Phase X $IDYA Phase 2/3 $KYTX Phase X $VOR Phase X $ATAI Phase 2b $INBX Phase X $KZR Phase 2a $PROK Phase X $ELDN Phase X $PVLA Phase X $NKTR Phase 2b $RZLT Phase X $RCUS Phase X $ASMB Phase X $BDTX Phase X $RNA Phase X $CAPR Phase X $TARA Phase X $ZVSA Phase 2a $CGON Phase X $VTYX Phase X $DBVT Phase X $PHVS Phase X $VTGN Phase X $TERN Phase X $ALEC Phase X $ZBIO Phase X $IRON Phase X $INBX Phase 2/3 $MLTX Phase 2"
X Link @BiopharmIQ 2025-09-28T19:33Z 27.4K followers, 41K engagements
"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q4 2025 (2/3). $ARGX Phase X $INCY Phase X $WVE Phase X $EWTX Phase X $RNAC Phase X $ROIV Phase X $GLPG Phase X $MGNX Phase X $BHVN Phase X $ANRO Phase X $PRAX Phase 2/3 $BHVN Phase X $COGT Phase X $ALKS Phase X $MRUS Phase X $MRUS Phase X $MRUS Phase X $ZNTL Phase X $IOVA Phase X $IOVA Phase X $AVXL Phase X $BBIO Phase X $GNLX Phase X $COYA Phase X $RXRX Phase X $PRTA Phase X $VALN Phase X $CGON Phase X $GNLX Phase X $EXEL Phase X $COGT Phase X $PCSA Phase X $IMVT Phase X $BMEA Phase X $EXEL Phase X $JAZZ Phase X $HOOK Phase X $ANRO"
X Link @BiopharmIQ 2025-09-28T19:33Z 27.4K followers, XXX engagements
"October Biotech PDUFA Pulse: ๐ก Whats on the FDA Radar $JAZZ - Zepzelca + Tecentriq - Approved $ARQT - ZORYVE (roflumilast) Cream XXXX% $AMGN - Tezspire $GKOS - Epioxa (Epi-on) $GSK - Blenrep combinations (BVd & BPd) $SNDX - Revuforj (revumenib) $MRK - WINREVAIR (sotatercept-csrk) $RHHBY - Gazyva/Gazyvaro $REGN - Libtayo (cemiplimab) Check out this months PDUFA calendar"
X Link @BiopharmIQ 2025-10-03T16:10Z 27.4K followers, 17.7K engagements
"๐ฃ Biotech Stock News 10/15 @ Open $OMER XXX% Asset purchase & license agreement $APLM XX% Resumes Trading $SPRC XX% Acquisition Agreement $ABSI XX% KOL Seminar on ABS-201 Program $XNCR X% Ph1 Dose-Escalation Results Presented $GYRE X% Completion of Patient Enrollment in Trial $SCYX X% Disagreement Resolved on Phase X Study $NVCR X% New Research for TTFields Therapy $HIMS X% Launches Menopause & Perimenopause Specialty $TEM X% Six Abstracts Accepted for ESMO 2025 $MNPR X% Abstract Accepted for Oral Presentation $ACOG X% Presenting Clinical Data at Meetings $AUPH X% Upcoming Presentations on"
X Link @BiopharmIQ 2025-10-15T15:42Z 27.4K followers, 9614 engagements
"๐งฌ Biotech Stock News 10/15 Brought to you by Barb On the rise ๐ $OMER XXX% $APLM XX% $SPRC XX% Under pressure ๐ $KROS -X% $EYPT -X% $AKTX -XX% Catch the full breakdown in the latest video"
X Link @BiopharmIQ 2025-10-15T17:27Z 27.4K followers, 3746 engagements
"๐ฃ Biotech Stock News 10/16 @ Open $PRAX XXX% Positive Topline Results Ph3 Studies $MIRA XX% Oral Mira-55 Outperforms Injected Morphine $CCCC XX% Pricing of $125M Offering $ANVS XX% Closing of $X Million Offering $GRAL XX% Strategic Collaboration for Multi-Cancer Test $PSNL XX% New Data from Lung Cancer Trial $NXTC XX% Expansion of Phase X Trial $CLLS XX% Hosts R&D Day Showcasing Pipeline $APLM X% Continued Nasdaq Listing After Hearing $VTGN X% Present at Menopause Society Annual Meeting $CTXR X% Exclusive Commercialization Agreement for LYMPHIR $ACET X% First Patient Dosed in Phase X Trial"
X Link @BiopharmIQ 2025-10-16T16:13Z 27.4K followers, 8475 engagements
"Try BPIQ API Free Get catalyst & pipeline data integrate seamlessly craft custom spreadsheets. ๐ Premium API access unlocks - full platform access - updated catalysts/pipeline data - & historical data for robust testing Check link below"
X Link @BiopharmIQ 2025-10-17T22:49Z 27.4K followers, 1392 engagements
"๐งฌ Biopharma Weekly Recap ๐ This week in biotech: Gene therapy and CRISPR roar back as $QURE M&A chatter heats up $NTLA leads in vivo race institutional money piles into GLP-1 giants and $XBIs rally signals sector revival. See interesting posts/ppl to check out ๐ @ericjackson ๐ Rate Cuts. Risk On. Biotech Reawakens. $SANA Looks Like the Next 100-Bagger Platform. @yaireinhorn BioTech & Pharma rebound: $XBI +9.5% since Sept XX +16.6% YTD. Recovery looks real but IPOs will be the true test. @mikeaxolotl Thesis: $QURE will be acquired for $8.5-11.4B+ within 6-18 months. That's 138-200%+ upside"
X Link @BiopharmIQ 2025-10-18T13:26Z 27.4K followers, 12K engagements
/creator/twitter::811036897883492352/posts